Furthermore, in the Rotterdam study, Oei et al. [37] measured Lp-PLA2 activity in 308 CHD cases and a random sample of 1,820 subjects and followed them for a median of 7.2 years. This evidence concerns the gene PLA2G7 and coronary artery disorder.